top of page

Delayed large skin reactions to Moderna Covid vaccine more common in women, older patients

Women and people aged 30 to 69 years may be at higher risk of developing a delayed large local reaction (DLLR) after receiving the mRNA-1273 Covid-19 vaccine from Moderna.

This finding comes from a Japanese study published online in JAMA Dermatology.

The investigators examined the associations between sex, age and susceptibility to DLLRs in a sample of 5,893 individuals who received the vaccine between May 24 and Nov. 30, 2021.

DLLR was considered if a participant reported redness, tenderness, itchiness, thickening or hardening of the skin, a burning sensation or swelling around the injection site on or after the sixth day after injection of the first dose of the vaccine.

Among the participants, 12.7% experienced DLLR symptoms after their first dose of the mRNA-1273 vaccine. Their DLLR symptoms were all mild.

Incidence rates of DLLR were higher in women (22.4%) compared to men (5.1%).

Broken down by age, the incidence rates among those aged 18 to 29 years was 9.0%, ages 30 to 39 years was 14.3%, 40 to 49 years was 15.8%, ages 50 to 59 years was 14.9% and 60 to 69 years was 12.6%.

"The association between demographic characteristics and susceptibility of DLLR suggests that the condition is a type IV allergic skin reaction," the authors write.


bottom of page